A. Onyenadum

Neoadjuvant chemotherapy with a combination of pegylated liposomal doxorubicin (Caelyx®) and paclitaxel in locally advanced breast cancer: a phase II study by the Hellenic Cooperative Oncology Group

Helen Gogas, Christos Papadimitriou, Haralabos P. Kalofonos et al. · Annals of Oncology · 2002 · 66 citations · Full text

Medicine, Oncology, Pharmacology +15

Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens

Christos Kosmas, Νicolas Tsavaris, Maria Vadiaka et al. · Cancer · 2001 · 37 citations · Full text

Medicine, Oncology, Pharmacology +15

Impact of providing booklets about chemotherapy to newly presenting patients with cancer: a randomized controlled trial

Gregoris Iconomou, A. Viha, I. Koukourikou et al. · Annals of Oncology · 2005 · 28 citations · Full text

Medicine, Oncology, Oncology Nursing +9

An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic co-operative Oncology Group.

D. Pectasides, Haralabos P. Kalofonos, Epaminontas Samantas et al. · PubMed · 2001 · 23 citations

Medicine, Oncology, Pharmacology +16

Carboplatin and Paclitaxel versus Cisplatin, Paclitaxel and Doxorubicin for first-line chemotherapy of Advanced Ovarian Cancer: A Hellenic Cooperative Oncology Group (HeCOG) study

Gerasimos Aravantinos, George Fountzilas, Aristotelis Bamias et al. · European Journal of Cancer · 2008 · 20 citations

Medicine, Gynecology, Oncology +12